Development, implementation and evaluation of the digital transformation of renal services in Wales: the journey from local to national

Author:

Mantzourani E.ORCID,Brooks O.,James D.,Richards A.,Hodson K.,Akhtar H.,Wakelyn M.,White L.,Williams R.,O’Gorman G.,Kervin A.,Chess J.,Brown C.

Abstract

Abstract Background Treatment for people with kidney disease is often associated with complicated combinations of medicines. Logistical challenges with traditiona paper-based prescribing means that these patients are particularly susceptible to medication-relation errors and harm. Aim To improve the quality of care that people with kidney disease receive across Wales through a Value-Based digital transformation programme. Setting Renal units within the National Welsh Renal Clinical Network (WRCN). Development A novel Electronic Prescribing & Medicines Administration (EPMA) system, integrated into a patient care record and linked to a patient portal was developed in South West Wales (SWW) region of the WRCN, enabled by the Welsh Government (WG) Efficiency Through Technology Fund. National upscale was enabled through the WG Transformation Fund. Implementation EPMA was designed and rolled out initially in SWW region of the WRCN (2018). A dedicated delivery team used the blueprint to finalise and implement a strategy for successful national roll-out eventually across all Wales (completed 2021). Evaluation A multi-factorial approach was employed, as both the technology itself and the healthcare system within which it would be introduced, were complex. Continuous cycles of action research involving informal and formal qualitative interviews with service-users ensured that EPMA was accessible and optimally engaging to all target stakeholders (patients and staff). Results confirmed that EPMA was successful in improving the quality of care that people with kidney disease receive across Wales, contributed to Value-Based outcomes, and put people who deliver and access care at the heart of transformation. Conclusion Key findings of this study align directly with the national design principles to drive change and transformation, put forward by the WG in their plan for Health and Social Care: prevention and early intervention; safety; independence; voice; seamless care.

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmaceutical Science,Pharmacology,Toxicology,Pharmacy

Reference39 articles.

1. Welsh Government. A Healthier Wales: our Plan for Health and Social care. 2018. https://gov.wales/sites/default/files/publications/2019-10/a-healthier-wales-action-plan.pdf. Accessed 07 Jun 2022

2. Welsh Renal Clinical Network. Renal Services in Wales 2016–2020 Delivery Plan. 2016. http://www.wales.nhs.uk/sites3/Documents/773/Renal%20Disease%20Quality%20Delivery%20Plan1.pdf. Accessed 07 Jun 2022

3. NHS. Treatment. In: Chronic kidney disease. 2019. https://www.nhs.uk/conditions/kidney-disease/treatment/. Accessed 07 Jun 2022

4. Chief Medical Officer for Wales’s special edition annual report 2019 to 2020: protecting our health. 2021. https://gov.wales/chief-medical-officer-waless-special-edition-annual-report-2019-2020-protecting-our-health. Accessed 08 Jun 2022

5. Shemilt K, Morecroft CW, Ford JL, et al. Inpatient prescribing systems used in NHS Acute Trusts across England: a managerial perspective. Eur J Hosp Pharm. 2017;24(4):213–7. https://doi.org/10.1136/ejhpharm-2016-000905.

Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3